PDE5 Inhibitor Use and Centrifugal Flow Left Ventricular Assist Device Outcomes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Postimplant Phosphodiesterase-5 Inhibitor Use in Centrifugal Flow Left Ventricular Assist Devices
JACC Heart Fail 2022 Feb 01;10(2)89-100, A Xanthopoulos, K Wolski, Q Wang, EH Blackstone, VK Randhawa, EG Soltesz, JB Young, SE Nissen, JD Estep, F Triposkiadis, RC StarlingFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.